about
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disordersATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimensProduction and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas.Targeting the indoleamine 2,3-dioxygenase pathway in cancerThe past, present and future of immunotherapy against tumorDatabase of T cell-defined human tumor antigens: the 2013 updateThe concept of immune surveillance against tumors. The first theoriesImaging Biomarkers in ImmunotherapyMouse homologue of the human SART3 gene encoding tumor-rejection antigenDendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumorsTumor-associated antigens as possible targets for immune therapy in head and neck cancer: comparative mRNA expression analysis of RAGE and GAGE genesGanoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activitiesEnhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoproteinProstate cancer immunotherapy at the dawn of the new millennium.PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme.A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes.Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines.Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction.Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library.Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell functionAntitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts.Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltrationPeptide mimic isolated by autoantibody reveals human arrest defective 1 overexpression is associated with poor prognosis for colon cancer patients.A high throughput method for identifying personalized tumor-associated antigensA novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia.Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis.Immunotherapy of cancer.Cancer gene therapy: hard lessons and new courses.Location, location, location: The relationship of anatomic site, antigen expression, and T-cell infiltration in human melanoma metastasesCT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis.Progress in cancer vaccines by enhanced self-presentationDirect visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.Management of malignant melanoma: new developments in immune and gene therapy.New methods for assessing T-cell responses.CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect.
P2860
Q22008829-CA5C12F5-193C-4D31-8305-0848E482CD59Q24531314-250932DB-8B14-46B1-AC92-DC272039699FQ24649090-809AD8FB-1052-4684-8B1E-DB2146776F40Q24814838-252C3A3E-7FE8-4C16-894A-60A3CF868578Q26775471-49C50D46-E973-4218-8478-1AA2EED90BFEQ26799896-8F046591-24A9-40D5-83CD-7830452BC1BAQ27022422-30D2AD10-FD6D-4972-8E02-198FD4C297F4Q28073937-34DA5659-0F7A-4D74-9AD3-E1BD93499E4FQ28079871-9DB3E6FE-581A-4B8D-8AE5-474DCC84CF65Q28141597-97AD12F1-B5AC-4F4F-9A0E-CA82EFC06ABAQ28183577-AA6BDE74-C956-4F53-9542-AF36B39BC5B6Q28219945-4A69132D-0B30-4E37-A6B1-61168D16CB79Q28302663-4279C5A4-4559-49D8-9315-411413A5FF69Q28383234-37157BB1-E0E1-482F-A126-A2AA95E3E3A5Q30327421-01CACC39-9011-4B1F-AF68-90F9473D0387Q30690737-1E6C5ECA-0A82-431C-B18E-9230E60EF662Q30700012-AA35642C-DFF9-4F03-A6C4-C55DE34955FCQ30785776-3AB148D7-8DE3-4C49-8EF3-A9FCFCA3D086Q30832171-2223BD50-7A3E-435E-AA7F-97EF2269EC71Q30894063-C5BF542C-84E0-4071-A14E-F17A62852AD2Q32142930-31BD8B1F-33D6-41C5-990C-BD698E2B15C2Q33181048-869BAB42-0F95-4193-A38B-FA069938F11FQ33184085-56FA2E85-79E5-4026-8893-CC207C099D5EQ33232102-5FB3C506-FC15-43EB-9A66-52F5A23D3184Q33281005-537B261E-B480-4F67-8F99-F7F2FF764792Q33357299-6659890E-7074-4BBC-AEE2-1E0D31996C70Q33624972-C23E7E0D-1198-4721-8B5C-4C6F4167889CQ33635219-DF73ACD1-5438-4E72-908F-31DC7E5534A8Q33658767-50911C46-3F9B-4E00-B814-7811203067A9Q33709910-F3E8FF1B-4552-47EE-9CE0-759B0142D1EAQ33728430-E451AB96-60CA-4C03-B4E8-C92463A844D3Q33833353-08CDD517-6A11-4E17-B46F-1BCDC8002DD7Q33840974-B369F2C4-4A2A-4833-9879-CF89AFDA8868Q33880126-4BB307CF-DB25-4A57-939B-F9362DD78626Q33892059-3F642257-8A04-4E8A-A680-5AF85C55B9FBQ33929076-8187AD94-9C17-43D6-B5A1-B6EA3EBE6E90Q34035564-A3978889-01AC-4B09-963E-85E7B66AD223Q34067644-0CD88744-C842-49E7-A99F-AB36A7A10151Q34076691-2A961D5C-943D-434D-BC0E-34629646E87BQ34095668-CAEF3E68-56F7-4E95-B26E-11C2920181F7
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Human tumor antigens recognized by T lymphocytes
@ast
Human tumor antigens recognized by T lymphocytes
@en
Human tumor antigens recognized by T lymphocytes
@nl
type
label
Human tumor antigens recognized by T lymphocytes
@ast
Human tumor antigens recognized by T lymphocytes
@en
Human tumor antigens recognized by T lymphocytes
@nl
prefLabel
Human tumor antigens recognized by T lymphocytes
@ast
Human tumor antigens recognized by T lymphocytes
@en
Human tumor antigens recognized by T lymphocytes
@nl
P2860
P921
P356
P1476
Human tumor antigens recognized by T lymphocytes
@en
P2093
P van der Bruggen
P2860
P356
10.1084/JEM.183.3.725
P407
P577
1996-03-01T00:00:00Z